about
Altered hypothalamic protein expression in a rat model of Huntington's diseaseMycobacterium tuberculosis FurA autoregulates its own expressionThe Mycobacterium tuberculosis Rv2358-furB operon is induced by zincGlutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegenerationAutomated phenotyping and advanced data mining exemplified in rats transgenic for Huntington's disease.Characterization of acid sphingomyelinase activity in human cerebrospinal fluidImpact of intracellular beta-amyloid in transgenic animals and cell models.Functional mapping of the promoter region of the GNB2L1 human gene coding for RACK1 scaffold protein.Capturing schizophrenia-like prodromal symptoms in a spinocerebellar ataxia-17 transgenic rat.Development of the first Gateway firefly luciferase vector and use of reverse transcriptase in FLOE (Fluorescently Labeled Oligonucleotide Extension) reactions.Rv2358 and FurB: two transcriptional regulators from Mycobacterium tuberculosis which respond to zinc.A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment.Expression, purification, and structural characterization of human histone H4.Dynamic footprint based locomotion sway assessment in α-synucleinopathic mice using Fast Fourier Transform and Low Pass Filter.DPP4-deficient congenic rats display blunted stress, improved fear extinction and increased central NPY.Early Alterations in Operant Performance and Prominent Huntingtin Aggregation in a Congenic F344 Rat Line of the Classical CAGn51trunc Model of Huntington Disease.In situ enzymatic activity of transglutaminase isoforms on brain tissue sections of rodents: A new approach to monitor differences in post-translational protein modifications during neurodegeneration.Dynamic footprints of α-synucleinopathic mice recorded by CatWalk gait analysis.Early postnatal behavioral, cellular, and molecular changes in models of Huntington disease are reversible by HDAC inhibition
P50
Q27314833-635BAD2C-3BD4-42DD-A366-1F48203C5E58Q28486632-70B87E57-F2BB-4BED-BBB1-2C6C98DF2A0EQ28487470-4F5EA011-7FCF-47D2-A9D1-204EC13E893AQ30446186-9A788C8D-9D9A-4854-9009-5804782CE5B6Q30836398-BEA00127-08CD-400E-9006-AD74CE0596F2Q34712835-904ACB74-DDA0-4176-A7FD-62E15BB7FD05Q37103004-E7EC8FBB-6775-45FE-A1F8-469556FA3ED6Q38359135-612F5B46-7F05-43BE-BBF0-5C78C1663EFDQ39179530-1AA6D3E5-D112-4EDD-A239-A0219ABA68C1Q40091686-E80E6990-C71B-45A8-9BEF-2AF8F8683E0AQ42949043-FC89D09D-01B4-4AF6-A302-811C7BD767F4Q43158553-CCDC47D0-DFD4-40EC-892F-8B1EA0F9A098Q43939588-8931A47F-849E-4686-8DA6-A2440EE1B873Q47239114-ED2AD8B5-10DA-490A-B5FF-602BE2D51F68Q47752660-CB47ACA1-F2A5-424C-9EFB-79AA122D28B5Q49560971-0F71463D-69BE-4995-97B9-1C524A653A82Q52145769-47F1A3D2-5F6C-40E9-8FC8-E7ADFBDA35F9Q55292318-D698A48C-C349-405A-9115-540604509E2AQ58700269-AAC3BD86-639B-4043-A12E-D4CC47683F9C
P50
name
Fabio Canneva
@en
type
label
Fabio Canneva
@en
prefLabel
Fabio Canneva
@en